A detailed history of Findell Capital Management LLC transactions in Liquidia Corp stock. As of the latest transaction made, Findell Capital Management LLC holds 3,193,539 shares of LQDA stock, worth $32.3 Million. This represents 16.08% of its overall portfolio holdings.

Number of Shares
3,193,539
Previous 400,000 698.38%
Holding current value
$32.3 Million
Previous $4.8 Billion 565.32%
% of portfolio
16.08%
Previous 2.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.9 - $14.11 $7.06 Million - $11.2 Million
793,539 Added 33.06%
3,193,539 $31.9 Billion
Q2 2024

Aug 14, 2024

BUY
$11.96 - $15.71 $3.53 Million - $4.63 Million
295,000 Added 14.01%
2,400,000 $28.8 Billion
Q1 2024

May 15, 2024

BUY
$11.35 - $16.73 $215,650 - $317,870
19,000 Added 0.91%
2,105,000 $31 Billion
Q4 2023

Feb 14, 2024

BUY
$5.77 - $12.19 $12 Million - $25.4 Million
2,086,000 New
2,086,000 $25.1 Billion

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $651M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Findell Capital Management LLC Portfolio

Follow Findell Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Findell Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Findell Capital Management LLC with notifications on news.